Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Why are Clinical Trials important?

Before a new treatment is tested in patients, it is carefully studied in the laboratory. First, a drug is considered because it changes cells or parts of cells in a way that suggests it will destroy cancer or help the body to deal with the side effects of cancer treatment. Then, the new treatment is tested in animals to learn what it does in the body. But this early research cannot predict exactly how a new treatment will work in people or define all the side effects that might occur. Clinical Trials are designed to help us find out how to give a new treatment safely and effectively to people. Each patient who participates in a Clinical Trial provides information on the effectiveness and risks of the new treatment. Advances in medicine and science are the result of new ideas and approaches developed through research. New cancer treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made available to all patients.

Treatments now being used (standard treatments) are the base for building new, hopefully better, treatments. Many standard treatments were first shown to be effective in Clinical Trials. Clinical Trials show researchers which therapies are more effective than others. This is the best way to identify an effective new treatment. New therapies are designed to take advantage of what has worked in the past and to improve on this base.

You may be interested in participating in a trial. You should learn as much as you can about the trial before you make up your mind.

Clinical Trials are the most reliable and best way of testing a new treatment, or of seeing whether one treatment works better than another. A new treatment is not always better, and can sometimes be worse than existing treatments. Trials are therefore really important when we need to know whether one treatment is safer and more effective than another.

We need Clinical Trials to improve treatment and care for patients now and in the future.

Many of the treatments now commonly used in the NHS have been tested through Clinical Trials. For example, in cancer care, trials have been used to try out new treatments – radiotherapy, chemotherapy, surgery, and complementary therapies. Trials have also been used to find out the best ways of using these treatments. This has meant that many people with cancer, HIV/AIDS and many other illnesses live longer and have a better quality of life.

Useful Medical Trial information

News

CTI Clinical Trial and Consulting Services acquires Eurotrials

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service CRO, with more than 20 years of experience, and strong local expertise in Europe and Latin America. The acquisition strengthens CTI’s existing Real World Evidence business, adding significant presence and expertise in Europe […]

more >

Evotec, CRTD partner to discover novel therapies for retinal diseases

Evotec has entered into a research collaboration with the Center for Regenerative Therapies TU Dresden (CRTD) to discover novel small molecule candidates for retinal diseases. CRTD is a recognized leader in understanding the biology of stem cells to develop new therapies for neurodegenerative and hematological diseases. Under the terms of the collaboration, Evotec will leverage […]

more >

Egalet receives FDA tentative approval for expanded label for ARYMO ER

Egalet, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced that the FDA has granted tentative approval for an expanded label for ARYMO ER (morphine sulfate) extended-release (ER) tablets C-II for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment […]

more >

Parkinson’s: Could this existing drug halt disease progression?

A 50-year-old drug that is commonly used to treat tapeworm infections is found to contain a molecule that can protect against Parkinson’s disease. Powered by WPeMatico

more >

Certara introduces New Investigator Awards program in Australia

Certara, a global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian […]

more >

CluePoints hires Borders and Estrella

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team. Nick Borders and Rob Estrella join the CluePoints U.S. team to support its impressive global business growth, allowing the company to increase its expanding client base across North […]

more >